Biologic Excipients Market
Market Insights on Biologic Excipients covering sales outlook, demand forecast & up-to-date key trends
Biologic Excipients Market by Excipients Type (Polymers, Sugar Alcohols, Polysorbates, Inorganic Salts, Amino Acids, Surfactants and Others) & Region for 2022-2028
Biologic Excipients Market Snapshot
[347 Pages Report] The global Biologic Excipients Market was valued US$ 1.3 Bn in 2021 and is expected to reach US$ 1.7 Bn by 2028, reflecting a cumulative CAGR of 3.4% over the forecast period (2022-2028) according to Future Market Insights (FMI) study.
|
Data Points |
Market Insights |
|
Market Value 2022 |
USD 1.4 Bn |
|
Market Value 2028 |
USD 1.7 Bn |
|
CAGR 2022 - 2028 |
3.4% |
|
Top 5 Countries % Share |
61.1% |
|
Key Players |
The key players in the Biologic Excipients market includes BASF Corporation, FMC Corporation, Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., Signet Chemical Co. Pvt. Ltd. |
The biologic excipients market is expanding due to rising demand for extended-release or sustained-release formulations and increasing demand for biologic excipients. Excipients are basically the small molecules that play an important role in the production of biologic drugs. Initiating mass manufacturing of biologic excipients for pharmaceutical purposes has been a crucial milestone in unlocking the potential for manufacturing pharmaceutical grade excipients to be employed in creating biologics.
Patent expiries has been pushing demand for functional excipients in the generics and biologics industry in large volumes. Product testing and manufacturing of novel biologics and biosimilars before a blockbuster patent expires is expected to fuel the requirement for biologic excipients globally. However, majority of testing and manufacturing of biologics is being outsourced to countries including China, India, and Brazil with good infrastructure and cheaper labor costs. As a result, the demand for biologic excipients in these countries is expected to increase significantly over the forecast period.
Demand for oral solid drug formulations has been witnessing steady increase over the past five years owing to ease of consumption by patient classes, including children. Oral dosage forms generally require more amount of excipients than other forms during the drug manufacturing process and is being promoted due to adoption of increased patient-centricity approaches by drug manufacturers
For example, over 50% of patients find it difficult to swallow conventional hard solid tablets. This has prompted drug companies to devise more innovative solid oral product forms such as orally disintegrating granules (ODGs), effervescent tablets, lozenges, instant drinks, and chewable tablets. This is expected to create substantial demand for excipients in the near future.
Drug manufacturers are gradually increasing outsourcing of their excipient R&D to CROs in order to enable significant cost savings. Outsourcing is being done either through full acquisition of CROs or by entering into long-term R&D contracts spanning in the forecast period.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1 - 2021 |
3.63% |
|
H1 – 2022 Projected |
3.38% |
|
H1 – 2022 Outlook |
3.28% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change– H1, 2022 (O) – H1, 2021 |
(-) 35 ↓ |
FMI presents a comparative analysis about the market growth rates and development prospects in the global biologic excipients market. The market is subject to influence by regulatory approvals and innovation factors in accordance with impact of macro and industry factors. Key developments in this market include developments in value chain, technological advancements, and expansion of R&D facilities.
According to Future Market Insight analysis, the biologic excipients market will drop by 35 Basis Point Share (BPS) in H1-2022 (O) as compared to H1-2021. The variation between the BPS values observed within this market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 BPS units.
Major reasons for this drop in BPS is attributed to the fact that emerging players do not adhere to International Pharmaceutical Excipients Council (IPEC) guidelines. Top players like Pfizer once could have incurred huge losses if they were subjected to strict audits back in the day.
In China, there have been instances where emerging players were facing issues in control over supply chain, data management, which conferred to product wastage and redundancy. Other market segments are expected to perform fairly and attain promising growth prospects in the next half of projection period.
Despite the factors, there are some plus points that stay ahead for the industry including demand for multi-functional biologic excipients, greater focus on the sustained release mechanism for biologics and emerging players entering into supply and distributor partnerships to expand their market reach.
2016-2021 Biologic Excipients Market Demand Outlook Compared to 2022 - 2028 Forecast
According to Future Market Insights (FMI), the biologic excipients value is US$ 1.3 Bn in 2021.
In 2021, the global market of biologic excipients accounts for approx. 17% of the overall pharmaceutical excipients market that was valued for around US$ 7.9 Bn.
The biologic excipients market is expected to grow at a strong pace in the forecast period. This is due to excipients' widespread use in the development of new therapies, as well as their capacity to improve the solubility of active pharmaceutical substances, among other things. Furthermore, the continuous evolution of drug delivery technology and the high frequency of autoimmune and inflammatory conditions are two major reasons that are expected to boost the biologic excipients market growth in the forecast period.
Increasing innovative collaborative research opportunities in pediatric formulations is being pushed through evolution of new regulations, additional funding opportunities, and increased public-private partnerships. This has been shifting focus to development of biologic excipients used in both oral solid and liquid pediatric formulations, which are flexible, dispersible and multi-functional. Furthermore, continued prioritization of unmet medical needs in pediatrics is expected to drive demand for these excipients and oral formulations in the forthcoming years
Sustained and extended release formulations are gaining popularity as they help in maintaining patient-safety through reduced number of medicine dosages, but having increased drug efficacy. From a commercial point of view, reduced dosing frequency improves treatment compliance, which could translate into higher unit sales and thus revenues. Furthermore, from the patient point of view, better therapeutic outcomes are expected due to improved drug tolerance and efficacy leading to lower switching costs and greater physician loyalty.
Over the past few years, development of sustained-release form of original drugs has gained traction in order to extend patent protection of biologic drugs. When compared with other biologic excipients, polymers offer long term delivery of injectable medicine. However, a new trend of combining sustained-release technology with targeted drug delivery allows to minimize systemic toxicity.
The market is fragmented and is dominated by players such as include, FMC Corporation , Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., Signet Chemical Co. Pvt. Ltd.
Future Market Insights expects the global biologic excipients market to grow at a CAGR of 3.4% by the end of 2028.
How is advanced drug delivery technologies boosting the Biologic Excipients Markets?
The ability of biologic excipients to offer increased efficacy of biologics through enhancement of solubility and bioavailability, enabling controlled/sustained release delivery performance coupled with introduction of innovative technologies focused to target pediatric and geriatric patient populations has made biologic excipients a key preference for biologic drug manufacturers. For instance, use of nanotechnology to manufacture biologic drugs is a recent trend that showcases the technological innovation in development of biologics.
Over the past few years, nanotechnology has been increasingly used in pharmaceutical industry owing to the fact that it improves API solubility, drug’s stability, and also enhances the pharmacological activity of drug with targeted delivery. Thus, with the emergence of such technologies, pharma manufacturers are focused to develop new techniques that enhances the capability of excipients.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Key Opportunities for Market Players?
Increasing Demand for multi-functional biologic excipients have been the window for investments as companies are expected to benefit from increased production of multi-functional excipients as these type of excipients enhances the formulation design. They help in generating sustained cost-savings throughout the drug production period.
Companies are expected to benefit from entering into contractual agreements with single distribution partners in emerging markets, along with strong local market knowledge. These economies, particularly India, China, and Brazil exhibit greater demand for healthcare services and products owing to increase in disposable income levels in these countries.
Additionally, Industry experts have noted that greater focus on innovations related to formulation of sustained-release small molecule drugs could provide potential revenue-generating opportunity for excipient manufacturers in the forecast period.
What is the Impact of the COVID-19 Crisis on the Market?
The pharma sector was severely impacted by the COVID-19 epidemic. The supply of raw materials from manufacturing hubs was interrupted by the lockdowns implemented in the wake of the epidemic. This hindered drug development and production, wreaking havoc on businesses that rely largely on outsourcing. Initially, the entire pharmaceutical ecosystem was thrown into disarray. Furthermore, regulatory authorities had to rethink and create new regulations in order to assure maximum patient safety following drug administration.
The pharmaceutical business gained traction once the lockdowns ended, owing to high demand for medications like hydroxychloroquine and Remdesivir, which showed promising effectiveness against COVID-19.
Excipients were critical in ensuring the safety and efficacy of medicines. Some companies saw revenue increase as a result of rising demand for certain drugs. For Instance, in March 31, 2020 excipientworld.org said that the excipients were the initials of drug formulation and during the pandemic, purified water has been the most vital excipients in formulating vaccines to fight COVID-19.
In the coming years, discoveries like these are expected to have a favorable impact on the biologic excipients business.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Insights
Will the U.S. Remain a Key Market for Biologic Excipients Markets?
In 2022, the U.S. is estimated to account for nearly 89.0 % value share in North America owing to existence of developed regulations and superior healthcare infrastructure.
Additionally, the demand is increasing in the U.S due to the increasing use of generic drugs that focus on delivering the highest quality and instant care to the patients in the industrial market in North America.
Why is Germany Considered a More Lucrative Market within Europe?
In 2022, Germany is expected to account for nearly 32.9%of the market in Europe. The rise in demand for the biologic excipients market is primarily due to the increasing aging population and chronic diseases, presence of well-established centers which provide quality care. Furthermore, favorable regulatory scenarios and increasing investments for the development of biologics and advanced dosage forms, will increase the demand for novel excipients in Germany market.
What are the Factors Supporting Biologic Excipients Market Sales in China?
The China market is expected to account for around 2.1% market revenue share in 2022 of the global biologic excipients market. The increase in research and development and availability of the medicine to treat symptoms instantly, expansion of the healthcare industry, and the rising need for efficient and safe healthcare practice and other therapeutics are the major factors driving the growth in China.
China also includes domestic market impact factors, regulatory change, favorable government policies and growing funding which affects current and future market trends.
Category-wise Insights
What is the Biologic Excipients Market value?
The market is expected to grow from US$ 1.3 Bn in 2021 to US$ 1.7 Bn in 2028, with a CAGR of around 3.4% over the forecast period (2022 - 2028).
Why the demand for polymers excipients is increasing?
In terms of product type-polymer excipients are anticipated to lead the biologic excipients market over the forecast period. The biologic segment holds the maximum share of 30.1% in 2021, expanding at 3.4% CAGR during the forecast period due to its availability at less cost as compared with other biologic excipients.
Additionally, polymers has been playing very important role in drug delivery systems by providing controlled release of therapeutic agents in constant doses over long periods.
Which segment accounts for the highest market share by end user?
By End User, biopharmaceutical manufacturer’s account for 65.5% and contract research organizations/contract manufacturing organizations accounts for 33.1% of the market share in 2021. These segments are expected to account for a relatively higher revenue share due to rising demand for biologic excipients with various combinations to provide stability and quality control for drug, and harnessing new scientific advances.
Competitive Landscape
Companies operating in the biologic excipients market are actively seeking to strengthen their position through acquisition and partnerships with established as well as emerging market players. The manufacturers have been prompting local drug makers to manufacture excipients in bulk at local facilities and supply them to biologic drug makers at very competitive prices.
Ensuring superior product quality and adherence to good manufacturing and ethical distribution practices are attributes followed diligently by branded drug makers for differentiating themselves to capitalize on the market share and capture the significant share of the market. Some of the recent instances include:
In November 2017, the company entered into partnership with DIEM Labs, to offer U.S. medical food product for the dietary management patients with Non-Alcoholic Fatty Liver Diseases (NAFLD).
On January 31, 2020, BASF closed the acquisition of Solvay’s polyamide business.
Leading industry players are focusing on the development of biologic excipients. Adoption of IPEC guidelines in both manufacturing and distribution is expected to propel adherence to measures, thus enhancing product safety and drug efficacy.
Scope Of The Report
|
Attribute |
Details |
|
Forecast Period |
2022 – 2028 |
|
Historical Data Available for |
2013-2021 |
|
Market Analysis |
USD Million for Value. |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
|
Key Segments Covered |
Excipients Type, End Users and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Biologic Excipients Market by Category
Excipient Type:
- Polymers
- Sugar Alcohols
- Polysorbates
- Inorganic Salts
- Amino Acids
- Surfactants
- Others
By End User:
- Biopharmaceutical Manufacturers
- Contract Research Organizations/Contract Manufacturing Organizations
- Research Organizations
Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- APECJ
- Middle East & Africa
- Japan
Frequently Asked Questions
What are the factors driving the demand outlook of the Biologic Excipients Market?
The global biologic excipients market is projected to reflect high demand in the forecast period with a CAGR of 3.4% owing to the increasing technological advancements in drug delivery systems.
Which is the most lucrative market for Biologic Excipients Market?
North America is expected to account for 44.9% of the global market share in the biologic excipients market with the U.S. being the leading contributor with a market value over US$ 558.4 Mn in 2022
How likely is the Biologic Excipients Market to grow in Japan?
The biologic excipients market in Japan is likely to grow at a CAGR of 2.7% during the forecast period, with a market share of around 1.2% in 2022.
What factors are driving demand for the Biologic Excipients Market?
Greater uptake of biologics driving demand for parenteral formulation, increasing acquisition of Contract Research Organizations (CROs) and patent-expiration of major blockbuster drugs have been the factors driving the biologic excipients market.
What are the top 5 countries driving demand for Biologic Excipients Market?
U.S., India, France, Canada, Germany are the top 5 countries that are driving the demand for the biologic excipients market.
Which are the leading companies of the Biologic Excipients Market?
Leading companies of biologic excipients market are BASF Corporation, FMC Corporation, Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., and Signet Chemical Co. Pvt. Ltd.
Table of Content
1. Executive Summary 1.1. Market Overview 1.2. Market Analysis 1.3. FMI Analysis and Recommendations 1.4. Wheel of Fortune 2. Market Introduction 2.1. Market Taxonomy 2.2. Market Definition 3. Biologic Excipients Market Opportunity Analysis 3.1. Macro-Economic Factors 3.2. Opportunity Analysis 4. Global Economic Outlook 4.1. Global Gross Domestic Product by Region & Country 4.2. Biologic Excipients Market Outlook 5. Market Background 5.1. List of Growth Hacking Manufacturers 5.2. Market Dynamics 5.2.1. Drivers 5.2.1.1. Supply Side Drivers 5.2.1.2. Demand Side Drivers 5.2.2. Restraints 6. Macroeconomic Assumptions 7. Global Economic Outlook 7.1. Gross Domestic Product by Region & Country, 2006 – 2021 8. Global Supply Demand Analysis 9. Key Inclusions 9.1. Key Competitors 9.2. Usage Trend In Biologic Excipients Industry 10. North America Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 10.3.1. U.S. 10.3.2. Canada 10.4. Market Size (US$ Mn) Forecast By Country, 2022–2028 10.4.1. U.S. 10.4.2. Canada 10.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021 10.5.1. Polymers 10.5.2. Sugar Alcohols 10.5.3. Polysorbates 10.5.4. Inorganic Salts 10.5.5. Amino Acids 10.5.6. Surfactants 10.5.7. Others 10.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028 10.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 10.7.1. Biopharmaceutical Manufacturers 10.7.2. Contract Research Organizations/Contract Manufacturing Organizations 10.7.3. Research Organizations 10.8. Market Size (US$ Mn) Forecast By End User, 2022–2028 10.9. Market Attractiveness Analysis 10.9.1. By Country 10.9.2. By Excipient Type 10.9.3. By End User 10.10. Key Market Participants – Intensity Mapping 10.11. Drivers and Restraints: Impact Analysis 11. Western Europe Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 11.3.1. Germany 11.3.2. U.K 11.3.3. France 11.3.4. Italy 11.3.5. Spain 11.3.6. Rest of Western Europe 11.4. Market Size (US$ Mn) Forecast By Country, 2022–2028 11.4.1. Germany 11.4.2. U.K 11.4.3. France 11.4.4. Italy 11.4.5. Spain 11.4.6. Rest of Western Europe 11.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021 11.5.1. Polymers 11.5.2. Sugar Alcohols 11.5.3. Polysorbates 11.5.4. Inorganic Salts 11.5.5. Amino Acids 11.5.6. Surfactants 11.5.7. Others 11.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028 11.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 11.7.1. Biopharmaceutical Manufacturers 11.7.2. Contract Research Organizations/Contract Manufacturing Organizations 11.7.3. Research Organizations 11.8. Market Size (US$ Mn) Forecast By End User, 2022–2028 11.9. Market Attractiveness Analysis 11.9.1. By Country 11.9.2. By Excipient Type 11.9.3. By End User 11.10. Key Market Participants – Intensity Mapping 11.11. Drivers and Restraints: Impact Analysis 12. Eastern Europe Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 12.3.1. Russia 12.3.2. Poland 12.3.3. Rest of Eastern Europe 12.4. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021 12.4.1. Polymers 12.4.2. Sugar Alcohols 12.4.3. Polysorbates 12.4.4. Inorganic Salts 12.4.5. Amino Acids 12.4.6. Surfactants 12.4.7. Others 12.5. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028 12.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 12.6.1. Biopharmaceutical Manufacturers 12.6.2. Contract Research Organizations/Contract Manufacturing Organizations 12.6.3. Research Organizations 12.7. Market Size (US$ Mn) Forecast By End User, 2022–2028 12.8. Market Attractiveness Analysis 12.8.1. By Country 12.8.2. By Excipient Type 12.8.3. By End User 12.9. Key Market Participants – Intensity Mapping 12.10. Drivers and Restraints: Impact Analysis 13. Latin America Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 13.1. Introduction 13.2. Regional Market Trends 13.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 13.3.1. Brazil 13.3.2. Mexico 13.3.3. Rest of Latin America 13.4. Market Size (US$ Mn) Forecast By Country, 2022–2028 13.4.1. Brazil 13.4.2. Mexico 13.4.3. Rest of Latin America 13.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021 13.5.1. Polymers 13.5.2. Sugar Alcohols 13.5.3. Polysorbates 13.5.4. Inorganic Salts 13.5.5. Amino Acids 13.5.6. Surfactants 13.5.7. Others 13.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028 13.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 13.7.1. Biopharmaceutical Manufacturers 13.7.2. Contract Research Organizations/Contract Manufacturing Organizations 13.7.3. Research Organizations 13.8. Market Size (US$ Mn) Forecast By End User, 2022–2028 13.9. Market Attractiveness Analysis 13.9.1. By Country 13.9.2. By Excipient Type 13.9.3. By End User 13.10. Key Market Participants – Intensity Mapping 13.11. Drivers and Restraints: Impact Analysis 14. Asia Pacific Excluding China & Japan Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 14.1. Introduction 14.2. Regional Market Trends 14.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 14.3.1. India 14.3.2. Australia and New Zealand 14.3.3. ASEAN 14.3.4. Rest of APECJ 14.4. Market Size (US$ Mn) Forecast By Country, 2022–2028 14.4.1. India 14.4.2. Australia and New Zealand 14.4.3. ASEAN 14.4.4. Rest of APECJ 14.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021 14.5.1. Polymers 14.5.2. Sugar Alcohols 14.5.3. Polysorbates 14.5.4. Inorganic Salts 14.5.5. Amino Acids 14.5.6. Surfactants 14.5.7. Others 14.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028 14.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 14.7.1. Biopharmaceutical Manufacturers 14.7.2. Contract Research Organizations/Contract Manufacturing Organizations 14.7.3. Research Organizations 14.8. Market Size (US$ Mn) Forecast By End User, 2022–2028 14.9. Market Attractiveness Analysis 14.9.1. By Country 14.9.2. By Excipient Type 14.9.3. By End User 14.10. Key Market Participants – Intensity Mapping 14.11. Drivers and Restraints: Impact Analysis 15. China Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 15.1. Introduction 15.2. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021 15.2.1. Polymers 15.2.2. Sugar Alcohols 15.2.3. Polysorbates 15.2.4. Inorganic Salts 15.2.5. Amino Acids 15.2.6. Surfactants 15.2.7. Others 15.3. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028 15.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 15.4.1. Biopharmaceutical Manufacturers 15.4.2. Contract Research Organizations/Contract Manufacturing Organizations 15.4.3. Research Organizations 15.5. Market Size (US$ Mn) Forecast By End User, 2022–2028 15.6. Market Attractiveness Analysis 15.6.1. By Excipient Type 15.6.2. By End User 15.7. Key Market Participants – Intensity Mapping 15.8. Drivers and Restraints: Impact Analysis 16. Japan Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 16.1. Introduction 16.2. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021 16.2.1. Polymers 16.2.2. Sugar Alcohols 16.2.3. Polysorbates 16.2.4. Inorganic Salts 16.2.5. Amino Acids 16.2.6. Surfactants 16.2.7. Others 16.3. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028 16.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 16.4.1. Biopharmaceutical Manufacturers 16.4.2. Contract Research Organizations/Contract Manufacturing Organizations 16.4.3. Research Organizations 16.5. Market Size (US$ Mn) Forecast By End User, 2022–2028 16.6. Market Attractiveness Analysis 16.6.1. By Excipient Type 16.6.2. By End User 16.7. Key Market Participants – Intensity Mapping 16.8. Drivers and Restraints: Impact Analysis 17. Middle East and Africa Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 17.1. Introduction 17.2. Regional Market Trends 17.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 17.3.1. GCC Countries 17.3.2. South Africa 17.3.3. Rest of MEA 17.4. Market Size (US$ Mn) Forecast By Country, 2022–2028 17.4.1. GCC Countries 17.4.2. South Africa 17.4.3. Rest of MEA 17.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021 17.5.1. Polymers 17.5.2. Sugar Alcohols 17.5.3. Polysorbates 17.5.4. Inorganic Salts 17.5.5. Amino Acids 17.5.6. Surfactants 17.5.7. Others 17.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028 17.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 17.7.1. Biopharmaceutical Manufacturers 17.7.2. Contract Research Organizations/Contract Manufacturing Organizations 17.7.3. Research Organizations 17.8. Market Size (US$ Mn) Forecast By End User, 2022–2028 17.9. Market Attractiveness Analysis 17.9.1. By Country 17.9.2. By Excipient Type 17.9.3. By End User 17.10. Key Market Participants – Intensity Mapping 17.11. Drivers and Restraints: Impact Analysis 18. Forecast Factors: Relevance and Impact 19. Forecast Assumptions 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competitors Deep Dive 20.3.1. Roquette Frères 20.3.1.1. Overview 20.3.1.2. Product and Application Portfolio 20.3.1.3. Production Footprint 20.3.1.4. Sales Footprint 20.3.1.5. Channel Footprint 20.3.1.6. Strategy 20.3.1.6.1.1. Marketing Strategy 20.3.1.6.1.2. Product Strategy 20.3.1.6.1.3. Channel Strategy 20.3.2. The Dow Chemical Company 20.3.2.1. Overview 20.3.2.2. Product and Application Portfolio 20.3.2.3. Production Footprint 20.3.2.4. Sales Footprint 20.3.2.5. Channel Footprint 20.3.2.6. Strategy 20.3.2.6.1.1. Marketing Strategy 20.3.2.6.1.2. Product Strategy 20.3.2.6.1.3. Channel Strategy 20.3.3. FMC Corporation 20.3.3.1. Overview 20.3.3.2. Product and Application Portfolio 20.3.3.3. Production Footprint 20.3.3.4. Sales Footprint 20.3.3.5. Channel Footprint 20.3.3.6. Strategy 20.3.3.6.1.1. Marketing Strategy 20.3.3.6.1.2. Product Strategy 20.3.3.6.1.3. Channel Strategy 20.3.4. Ashland Inc. 20.3.4.1. Overview 20.3.4.2. Product and Application Portfolio 20.3.4.3. Production Footprint 20.3.4.4. Sales Footprint 20.3.4.5. Channel Footprint 20.3.4.6. Strategy 20.3.4.6.1.1. Marketing Strategy 20.3.4.6.1.2. Product Strategy 20.3.4.6.1.3. Channel Strategy 20.3.5. Signet Chemical Corporation Pvt. Ltd. 20.3.5.1. Overview 20.3.5.2. Product and Application Portfolio 20.3.5.3. Production Footprint 20.3.5.4. Sales Footprint 20.3.5.5. Channel Footprint 20.3.5.6. Strategy 20.3.5.6.1.1. Marketing Strategy 20.3.5.6.1.2. Product Strategy 20.3.5.6.1.3. Channel Strategy 20.3.6. BASF Corporation 20.3.6.1. Overview 20.3.6.2. Product and Application Portfolio 20.3.6.3. Production Footprint 20.3.6.4. Sales Footprint 20.3.6.5. Channel Footprint 20.3.6.6. Strategy 20.3.6.6.1.1. Marketing Strategy 20.3.6.6.1.2. Product Strategy 20.3.6.6.1.3. Channel Strategy 20.3.7. Colorcon 20.3.7.1. Overview 20.3.7.2. Product and Application Portfolio 20.3.7.3. Production Footprint 20.3.7.4. Sales Footprint 20.3.7.5. Channel Footprint 20.3.7.6. Strategy 20.3.7.6.1.1. Marketing Strategy 20.3.7.6.1.2. Product Strategy 20.3.7.6.1.3. Channel Strategy 20.3.8. The Archer Daniels Midland Company 20.3.8.1. Overview 20.3.8.2. Product and Application Portfolio 20.3.8.3. Production Footprint 20.3.8.4. Sales Footprint 20.3.8.5. Channel Footprint 20.3.8.6. Strategy 20.3.8.6.1.1. Marketing Strategy 20.3.8.6.1.2. Product Strategy 20.3.8.6.1.3. Channel Strategy 20.3.9. Wacker Chemie AG 20.3.9.1. Overview 20.3.9.2. Product and Application Portfolio 20.3.9.3. Production Footprint 20.3.9.4. Sales Footprint 20.3.9.5. Channel Footprint 20.3.9.6. Strategy 20.3.9.6.1.1. Marketing Strategy 20.3.9.6.1.2. Product Strategy 20.3.9.6.1.3. Channel Strategy 20.3.10. DuPont 20.3.10.1. Overview 20.3.10.2. Product and Application Portfolio 20.3.10.3. Production Footprint 20.3.10.4. Sales Footprint 20.3.10.5. Channel Footprint 20.3.10.6. Strategy 20.3.10.6.1.1. Marketing Strategy 20.3.10.6.1.2. Product Strategy 20.3.10.6.1.3. Channel Strategy 20.3.11. Evonik Industries 20.3.11.1. Overview 20.3.11.2. Product and Application Portfolio 20.3.11.3. Production Footprint 20.3.11.4. Sales Footprint 20.3.11.5. Channel Footprint 20.3.11.6. Strategy 20.3.11.6.1.1. Marketing Strategy 20.3.11.6.1.2. Product Strategy 20.3.11.6.1.3. Channel Strategy 21. Global Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 By Region 21.1. Introduction / Key Findings 21.2. Historical Market Size (US$ Mn) Analysis By Region 21.2.1. North America 21.2.2. Western Europe 21.2.3. Eastern Europe 21.2.4. Latin America 21.2.5. Asia Pacific Excluding Japan And China 21.2.6. China 21.2.7. Japan 21.2.8. Middle East and Africa 21.3. Market Size (US$ Mn) Forecast By Region 21.3.1. North America 21.3.2. Western Europe 21.3.3. Eastern Europe 21.3.4. Latin America 21.3.5. Asia Pacific Excluding Japan And China 21.3.6. China 21.3.7. Japan 21.3.8. Middle East and Africa 21.4. Market Attractiveness Analysis By Region 22. Global Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028, By Excipient Type 22.1. Introduction/Key Finding 22.2. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021 22.2.1. Polymers 22.2.2. Sugar Alcohols 22.2.3. Polysorbates 22.2.4. Inorganic Salts 22.2.5. Amino Acids 22.2.6. Surfactants 22.2.7. Others 22.3. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028 22.4. Market Attractiveness Analysis By Excipient Type 23. Global Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028, By End User 23.1. Introduction/Key Finding 23.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 23.2.1. Biopharmaceutical Manufacturers 23.2.2. Contract Research Organizations/Contract Manufacturing Organizations 23.2.3. Research Organizations 23.3. Market Size (US$ Mn) Forecast By End User, 2022–2028 24. Global Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 24.1. Market Value Share Analysis By All Segment 24.2. Y-o-Y Growth Analysis By All Segment 24.3. Absolute $ Opportunity 25. Assumptions and Acronyms Used 26. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: List of Commercial Monoclonal Antibody Products and their Excipients, By Company Table 02: Frequency of Excipient Inclusion in MAb Formulations (%) Table 03: Excipient Composition, By Monoclonal Antibody (MAb) Table 04: Excipient Composition, By Insulin Table 05: Excipient Composition, By Human Growth Hormone (HGH) Table 06: Excipient Composition, By Interferon (INF) Table 07: Excipient Composition, By Granulocyte-Colony Stimulating Factors (G-CSFs) Table 08: North America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country Table 09: North America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient Table 10: North America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User Table 11: Latin America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country Table 12: Latin America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient Table 13: Latin America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User Table 14: Western Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country Table 15: Western Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient Table 16: Western Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User Table 17: Eastern Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country Table 18: Eastern Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient Table 19: Eastern Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User Table 20: APECJ Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country Table 21: APECJ Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient Table 22: APECJ Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User Table 23: Japan Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient Table 24: Japan Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User Table 25: China Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient Table 26: China Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User Table 27: MEA Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country Table 28: MEA Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient Table 29: MEA Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User Table 30: Global Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Region Table 31: Global Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient Table 32: Global Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Value Share 2022E, By Excipient Type Figure 02: Global Biologic Excipients Market Revenue Opportunity Analysis, By Country 2018-2028 Figure 03: Global Biologic Excipients Market, 2021A Figure 04: GDP (US$ Trillion) and Healthcare Expenditure % (2020) Figure 05: Global Healthcare Expenditure in US$ Tn (2013–2020) Figure 05: Global Healthcare Expenditure in US$ Tn (2013–2020) Figure 06: North America Biologic Excipients Market Value Share, By Excipient Type (2021A) Figure 07: North America Biologic Excipients Market Value Share (2021A), By End User Figure 08: North America Biologic Excipients Market Value Share (2021A), By Country Figure 09: North America Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 10: North America Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 11: U.S. Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 12: U.S. Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 13: Canada Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 14: Canada Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 15: North America Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 16: North America Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 17: North America Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 18: North America Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 19: North America Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 20: North America Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 21: North America Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 22: North America Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 23: North America Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 24: North America Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 25: North America Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 26: North America Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 27: North America Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 28: North America Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 29: North America Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021 Figure 30: North America Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 31: North America Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 32: North America CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 33: North America Research Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 34: North America Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 35: North America Biologic Excipients Market Attractiveness Analysis, By Excipient Type Figure 36: North America Biologic Excipients Market Attractiveness Analysis, By End User Figure 37: North America Biologic Excipients Market Attractiveness Analysis, By Country Figure 38: Latin America Biologic Excipients Market Value Share, By Excipient Type (2021A) Figure 39: Latin America Biologic Excipients Market Value Share (2021A), By End User Figure 40: Latin America Biologic Excipients Market Value Share (2021A), By Country Figure 41: Latin America Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 42: Latin America Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 43: Brazil Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 44: Brazil Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 45: Mexico Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 46: Mexico Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 47: Rest of Latin America Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 48: Rest of Latin America Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 49: Latin America Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 50: Latin America Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 51: Latin America Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 52: Latin America Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 53: Latin America Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 54: Latin America Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 55: Latin America Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 56: Latin America Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 57: Latin America Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 58: Latin America Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 59: Latin America Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 60: Latin America Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 61: Latin America Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 62: Latin America Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 63: Latin America Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021 Figure 64: Latin America Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 65: Latin America Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 66: Latin America CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 67: Latin America Research Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 68: Latin America Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 69: Latin America Biologic Excipients Market Attractiveness Analysis, By Excipient Type Figure 70: Latin America Biologic Excipients Market Attractiveness Analysis, By End User Figure 71: Latin America Biologic Excipients Market Attractiveness Analysis, By Country Figure 72: Western Europe Biologic Excipients Market Value Share, By Excipient Type (2021A) Figure 73: Western Europe Biologic Excipients Market Value Share (2021A), By End User Figure 74: Western Europe Biologic Excipients Market Value Share (2021A), By Country Figure 75: Western Europe Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 76: Western Europe Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 77: Germany Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 78: Germany Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 79: Spain Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 80: Spain Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 81: U.K Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 82: U.K Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 83: Italy Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 84: Italy Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 85: France Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 86: France Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 87: Rest of Europe Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 88: Rest of Europe Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 89: Western Europe Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 90: Western Europe Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 91: Western Europe Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 92: Western Europe Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 93: Western Europe Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 94: Western Europe Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 95: Western Europe Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 96: Western Europe Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 97: Western Europe Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 98: Western Europe Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 99: Western Europe Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 100: Western Europe Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 101: Western Europe Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 102: Western Europe Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 103: Western Europe Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021 Figure 104: Western Europe Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 105: Western Europe Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 106: Western Europe CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 107: Western Europe Research Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 108: Western Europe Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 109: Western Europe Biologic Excipients Market Attractiveness Analysis, By Excipient Type Figure 110: Western Europe Biologic Excipients Market Attractiveness Analysis, By End User Figure 111: Western Europe Biologic Excipients Market Attractiveness Analysis, By Country Figure 112: Eastern Europe Biologic Excipients Market Value Share, By Excipient Type (2021A) Figure 113: Eastern Europe Biologic Excipients Market Value Share (2021A), By End User Figure 114: Eastern Europe Biologic Excipients Market Value Share (2021A), By Country Figure 115: Eastern Europe Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 116: Eastern Europe Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 117: Russia Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 118: Russia Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 119: Poland Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 120: Poland Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 121: Rest of Eastern Europe Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 122: Rest of Eastern Europe Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 123: Eastern Europe Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 124: Eastern Europe Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 125: Eastern Europe Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 126: Eastern Europe Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 127: Eastern Europe Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 128: Eastern Europe Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 129: Eastern Europe Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 130: Eastern Europe Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 131: Eastern Europe Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 132: Eastern Europe Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 133: Eastern Europe Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 134: Eastern Europe Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 135: Eastern Europe Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 136: Eastern Europe Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 137: Eastern Europe Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021 Figure 138: Eastern Europe Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 139: Eastern Europe Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 140: Eastern Europe CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 141: Eastern Europe Research Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 142: Eastern Europe Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 143: Eastern Europe Biologic Excipients Market Attractiveness Analysis, By Excipient Type Figure 144: Eastern Europe Biologic Excipients Market Attractiveness Analysis, By End User Figure 145: Eastern Europe Biologic Excipients Market Attractiveness Analysis, By Country Figure 146: APECJ Biologic Excipients Market Value Share, By Excipient Type (2021A) Figure 147: APECJ Biologic Excipients Market Value Share (2021A), By End User Figure 148: APECJ Biologic Excipients Market Value Share (2021A), By Country Figure 149: APECJ Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 150: APECJ Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 151: India Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 152: India Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 153: Australia & New Zealand Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 154: Australia & New Zealand Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 155: ASEAN Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 156: ASEAN Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 157: Rest of APECJ Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 158: Rest of APECJ Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 159: APECJ Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 160: APECJ Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 161: APECJ Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 162: APECJ Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 163: APECJ Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 164: APECJ Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 165: APECJ Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 166: APECJ Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 167: APECJ Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 168: APECJ Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 169: APECJ Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 170: APECJ Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 171: APECJ Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 172: APECJ Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 173: APECJ Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021 Figure 174: APECJ Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 175: APECJ Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 176: APECJ CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 177: APECJ Research Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 178: APECJ Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 179: APECJ Biologic Excipients Market Attractiveness Analysis, By Excipient Type Figure 180: APECJ Biologic Excipients Market Attractiveness Analysis, By End User Figure 181: APECJ Biologic Excipients Market Attractiveness Analysis, By Country Figure 182: Japan Biologic Excipients Market Value Share, By Excipient Type (2021A) Figure 183: Japan Biologic Excipients Market Value Share (2021A), By End User Figure 184: Japan Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 185: Japan Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 186: Japan Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 187: Japan Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 188: Japan Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 189: Japan Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 190: Japan Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 191: Japan Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 192: Japan Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 193: Japan Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 194: Japan Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 195: Japan Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 196: Japan Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 197: Japan Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 198: Japan Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 199: Japan Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 200: Japan Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021 Figure 201: Japan Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 202: Japan Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 203: Japan CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 204: Japan Research Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 205: Japan Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 206: Japan Biologic Excipients Market Attractiveness Analysis, By Excipient Type Figure 207: Japan Biologic Excipients Market Attractiveness Analysis, By End User Figure 208: China Biologic Excipients Market Value Share, By Excipient Type (2021A) Figure 209: China Biologic Excipients Market Value Share (2021A), By End User Figure 210: China Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 211: China Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 212: China Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 213: China Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 214: China Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 215: China Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 216: China Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 217: China Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 218: China Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 219: China Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 220: China Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 221: China Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 222: China Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 223: China Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 224: China Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 225: China Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 226: China Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021 Figure 227: China Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 228: China Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 229: China CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 230: China Research Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 231: China Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 232: China Biologic Excipients Market Attractiveness Analysis, By Excipient Type Figure 233: China Biologic Excipients Market Attractiveness Analysis, By End User Figure 234: MEA Biologic Excipients Market Value Share, By Excipient Type (2021A) Figure 235: MEA Biologic Excipients Market Value Share (2021A), By End User Figure 236: MEA Biologic Excipients Market Value Share (2021A), By Country Figure 237: MEA Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 238: MEA Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 239: GCC Countries Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 240: GCC Countries Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 241: South Africa Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 242: South Africa Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 243: Rest of MEA Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 244: Rest of MEA Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 245: MEA Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 246: MEA Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 247: MEA Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 248: MEA Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 249: MEA Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 250: MEA Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 251: MEA Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 252: MEA Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 253: MEA Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 254: MEA Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 255: MEA Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 256: MEA Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 257: MEA Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021 Figure 258: MEA Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 259: MEA Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021 Figure 260: MEA Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 261: MEA Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 262: MEA CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 263: MEA Research Organizations Market size (US$ Mn) Analysis, 2013–2021 Figure 264: MEA Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 265: MEA Biologic Excipients Market Attractiveness Analysis, By Excipient Type Figure 266: MEA Biologic Excipients Market Attractiveness Analysis, By End User Figure 267: MEA Biologic Excipients Market Attractiveness Analysis, By Country Figure 268: Global Biologic Excipients Market Share Analysis (%) By Region, 2022 & 2028 Figure 269: Global Biologic Excipients Market Y-o-Y Growth (%) By Region, 2022–2028 Figure 270: Global Biologic Excipients Market Attractiveness Analysis By Region, 2022–2028 Figure 271: Global Biologic Excipients Market Share Analysis (%) By Excipient, 2022 & 2028 Figure 272: Global Biologic Excipients Market Y-o-Y Growth (%) By Excipient, 2022–2028 Figure 273: Global Biologic Excipients Market Attractiveness Analysis By Excipient, 2022–2028 Figure 274: Global Biologic Excipients Market Share Analysis (%) By End User, 2022 & 2028 Figure 275: Global Biologic Excipients Market Y-o-Y Growth (%) By End User, 2022–2028 Figure 276: Global Biologic Excipients Market Attractiveness Analysis By End User, 2022–2028 Figure 277: Global Biologic Excipients Market Value Analysis and Forecast, 2021–2028 (US$ Mn) Figure 278: Global Biologic Excipients Market Value (US$ Mn), 2013–2021 Figure 279: Global Biologic Excipients Market Absolute $ Opportunity (US$ Mn), 2021–2028
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
